Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
批准号:
8106627
负责人:
PETER A COHEN
金额:
$37.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2015-07-31
关键词:
AblationAddressAnimalsAutoimmunityBehaviorBiologicalBiological ProcessBone MarrowCell physiologyCellsDataDevelopmentDiseaseEquilibriumGenomicsGoalsGrowthHypersensitivityITGAM geneImmuneImmune ToleranceImmune responseImmune systemImmunityLeadLearningLiverMediatingMetastatic LesionMusOrgan TransplantationPopulationPrimary NeoplasmRegulationRoleSpleenStagingT-Cell ProliferationT-LymphocyteTestingThymus GlandTimeTime StudyTissuesTumor ImmunityTumor Promotionbasecytokinedesignin vivoinsightlymph nodesmacrophagemicrobialneoplastic celloral toleranceperipheral bloodpreventtumortumor growthtumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have identified a new population of CD11b+F4/80+CD68+ (macrophages) that express Foxp3. Our initial results indicate that these cells were observed in spleen, lymph nodes, bone marrow, thymus, peripheral blood, liver and other tissues. We devised a strategy to highly purify CD11b+F4/80+Foxp3+ macrophages using the Foxp3-GFP mice. Our results show that CD11b+F4/80+ macrophages expressing Foxp3 inhibited the proliferation of T cells whereas Foxp3neg macrophages did not. Foxp3pos macrophages inhibited the proliferation of T cells through cell: cell contact mechanisms or soluble factors. Ablation of Foxp3 expression on CD11b+F4/80+Foxp3+ cells results in their lost capacity to inhibit the proliferation of T cells confirming that Foxp3 is directly responsible for conferring suppressive capabilities to this subpopulation of macrophages. The cytokine and genomic profiles of Foxp3pos and Foxp3neg macrophages were distinctive indicating that these cells have different biological functions. Furthermore, Foxp3pos macrophages induce de novo conversion Tregs, in contrast Foxp3neg macrophages did not. Functional analysis indicated that CD11b+F4/80+Foxp3+ macrophages are important for tolerance induction and are involved as well in tumor promotion and progression. For the first time, these studies demonstrate the existence of a distinct subpopulation of naturally occurring macrophage regulatory cells (Mac-regs) in which their suppressive function is directly correlated to the expression of Foxp3. Taken together our preliminary results lead to hypothesize that CD11b+F4/80+Foxp3+ cells (Mac-regs) subpopulation is an important subset of regulatory cells critical in the homeostatic balance of the immune system regulating immune responses which contribute to T cell tolerance induction and tumor promotion/growth. In order to test our hypothesis the following specific aims will be addressed: Aim 1 will define the mechanisms by which Mac-regs inhibit other cells; Aim 2 will evaluate the mechanism of tolerance induction by Mac-regs; and Aim 3 will evaluate the role of Mac-regs in tumor promotion and growth.
PUBLIC HEALTH RELEVANCE: For the first time we have identified a population of macrophages that express Foxp3. The Foxp3+ MX are able to inhibit the effector function of T cells. In vivo biological functions of Foxp3+ MX indicate that these induce immune tolerance and are important in promoting tumor growth. These results indicate that Foxp3+ MX are an important subset of regulatory cells critical in the homeostatic balance of the immune system. Learning more about the behavior of Foxp3+ MX is critical to understand the pathological function of these cells which could be related to tolerance, autoimmunity, tumor immunity, organ transplantation, allergy, and microbial immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
-
批准号:8738913
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2014
-
负责人:PETER A COHEN
-
依托单位:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
-
批准号:8309017
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:PETER A COHEN
-
依托单位:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
-
批准号:8501323
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2011
-
负责人:PETER A COHEN
-
依托单位:
Role of Macrophage Regulatory Cells (Mac-regs) in Immune Regulation
-
批准号:8708747
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2011
-
负责人:PETER A COHEN
-
依托单位:
Sunitinib Modulation of Cancer Immunotherapy
-
批准号:8606436
-
项目类别:
-
资助金额:$50.16万
-
财政年份:2010
-
负责人:PETER A COHEN
-
依托单位:
Sunitinib Modulation of Cancer Immunotherapy
-
批准号:8110572
-
项目类别:
-
资助金额:$54.87万
-
财政年份:2010
-
负责人:PETER A COHEN
-
依托单位:
Sunitinib Modulation of Cancer Immunotherapy
-
批准号:8212575
-
项目类别:
-
资助金额:$52.84万
-
财政年份:2010
-
负责人:PETER A COHEN
-
依托单位:
Sunitinib Modulation of Cancer Immunotherapy
-
批准号:8449500
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2010
-
负责人:PETER A COHEN
-
依托单位:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
-
批准号:8475569
-
项目类别:
-
资助金额:$55.48万
-
财政年份:2009
-
负责人:PETER A COHEN
-
依托单位:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
-
批准号:8720513
-
项目类别:
-
资助金额:$57.01万
-
财政年份:2009
-
负责人:PETER A COHEN
-
依托单位:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy.
-
批准号:7564874
-
项目类别:
-
资助金额:$58.29万
-
财政年份:2009
-
负责人:PETER A COHEN
-
依托单位:
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
-
批准号:8249636
-
项目类别:
-
资助金额:$61.1万
-
财政年份:2009
-
负责人:PETER A COHEN
-
依托单位:
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
-
批准号:7302499
-
项目类别:
-
资助金额:$29.36万
-
财政年份:2007
-
负责人:PETER A COHEN
-
依托单位:
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
-
批准号:7846837
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2007
-
负责人:PETER A COHEN
-
依托单位:
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
-
批准号:7626418
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2007
-
负责人:PETER A COHEN
-
依托单位:
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
-
批准号:7737292
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2007
-
负责人:PETER A COHEN
-
依托单位:
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
-
批准号:7473880
-
项目类别:
-
资助金额:$13.18万
-
财政年份:2007
-
负责人:PETER A COHEN
-
依托单位:
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
-
批准号:7010325
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2001
-
负责人:PETER A COHEN
-
依托单位:
CD8+ HELPER-INDEPENDENT T CELLS IN TUMOR THERAPY
-
批准号:7163457
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2001
-
负责人:PETER A COHEN
-
依托单位:
CD8+ HELPER INDEPENDENT T CELLS IN TUMOR THERAPY
-
批准号:6489415
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2001
-
负责人:PETER A COHEN
-
依托单位:
海外基金